Glytec Overview
- Year Founded
-
2006
- Status
-
Private
- Employees
-
79
- Latest Deal Type
-
Series K
- Latest Deal Amount
-
$10M
- Investors
-
2
Glytec General Information
Description
Developer of a cloud-based insulin management platform designed to improve diabetes care and insulin dosing in clinical settings. The company offers FDA-cleared, integrated software supported by patented technology and real-time decision support tools, enabling hospitals and healthcare providers to enhance patient safety, reduce readmissions, and streamline clinical workflows.
Contact Information
Website
glytec.comCorporate Office
- 2300 Windy Ridge Parkway South East
- Suite S-1125
- Atlanta, GA 30339
- United States
Corporate Office
- 2300 Windy Ridge Parkway South East
- Suite S-1125
- Atlanta, GA 30339
- United States
Glytec Timeline
Glytec Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 18. Later Stage VC (Series K) | 25-Sep-2026 | $10M | Completed | Generating Revenue | ||
| 17. Later Stage VC | 17-Jun-2025 | Completed | Generating Revenue | |||
| 16. Debt - PPP | 11-Aug-2023 | Completed | Generating Revenue | |||
| 15. Later Stage VC | 26-Apr-2021 | Completed | Generating Revenue | |||
| 14. Later Stage VC (Series J) | 29-May-2020 | Completed | Generating Revenue | |||
| 13. Later Stage VC (Series I) | 14-Oct-2019 | Completed | Generating Revenue | |||
| 12. Later Stage VC (Series H) | 07-Jun-2017 | Completed | Generating Revenue | |||
| 11. Later Stage VC (Series G) | 21-Mar-2016 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series F) | 20-Aug-2015 | $5.1M | $32M | Completed | Generating Revenue | |
| 9. Later Stage VC (Series E) | 14-Aug-2014 | $2.5M | $26.9M | Completed | Generating Revenue |
Glytec Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series J | ||||||||
| Series I | ||||||||
| Series H-1 | ||||||||
| Series H | ||||||||
| Series G-1 | ||||||||
| Series G | ||||||||
| Series F1 | ||||||||
| Series F | ||||||||
| Series E | 622,763 | $0.001000 | 8% | $7.4 | $7.4 | 1x | $6.91 | 0.14% |
| Series D | 821,357 | $0.001000 | 8% | $6.73 | $6.73 | 1x | $6.44 | 0.18% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Glytec Comparisons
Industry
Financing
Details
Glytec Competitors (14)
One of Glytec’s 14 competitors is Omada, a Formerly VC-backed company based in Dallas, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Omada | Formerly VC-backed | Dallas, TX | ||||
| Lark | Venture Capital-Backed | Mountain View, CA | ||||
| Canary Health | Formerly VC-backed | Los Angeles, CA | ||||
| Health2Sync | Venture Capital-Backed | Taipei, Taiwan | ||||
| Welldoc | Venture Capital-Backed | Columbia, MD |
Glytec Patents
Glytec Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023173129-A1 | Advising diabetes treatments | Inactive | 11-Mar-2022 | ||
| US-11481130-B2 | Method, electronic device and computer program product for processing operation commands | Active | 31-Jul-2020 | ||
| US-20220035527-A1 | Method, electronic device and computer program product for processing operation commands | Active | 31-Jul-2020 | ||
| US-12205698-B2 | Advising diabetes medications | Active | 21-Dec-2017 | ||
| US-20240170123-A1 | Advising diabetes medications | Active | 21-Dec-2017 | G16H20/13 |
Glytec Signals
Glytec Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Hayfin Capital Management | Asset Manager | Minority | ||
| Savitr Capital | Venture Capital | Minority |
Glytec FAQs
-
When was Glytec founded?
Glytec was founded in 2006.
-
Where is Glytec headquartered?
Glytec is headquartered in Atlanta, GA.
-
What is the size of Glytec?
Glytec has 79 total employees.
-
What industry is Glytec in?
Glytec’s primary industry is Enterprise Systems (Healthcare).
-
Is Glytec a private or public company?
Glytec is a Private company.
-
What is Glytec’s current revenue?
The current revenue for Glytec is .
-
How much funding has Glytec raised over time?
Glytec has raised $127M.
-
Who are Glytec’s investors?
Hayfin Capital Management and Savitr Capital have invested in Glytec.
-
Who are Glytec’s competitors?
Omada, Lark, Canary Health, Health2Sync, and Welldoc are some of the 14 competitors of Glytec.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process